The Central Drugs Standard Control Organization (CDSCO), drug regulator for India's Health Ministry, approved two more Covid vaccines, Corbevax and Covovax, as also the anti-viral drug Molnupiravir to treat adult patients with COVID-19 as also those who have a high risk of progression of the disease. Corbevax: This vaccine is...
India Administers 1 Billion Doses of the Covid-19 Vaccine
India has crossed the landmark of vaccinating 1 billion individuals in about nine months since the drive began. The countrywide vaccination program was launched on January 16 with the aim of covering all of India’s 944 million adults this year. As of now, 75% of them have got at least...
Serum Institute of India Partners with SCHOTT AG for Pharmaceutical Packaging
Germany's specialty glass company SCHOTT AG and Serum Institute of India, the world‘s largest vaccine producer and manufacturer of biologics, have formed a joint venture for pharma packaging products such as vials, syringes, ampoules and cartridges. Serum Institute bought the 50% stake in the Indian joint venture SCHOTT Kaisha from...
Serum Institute Preps for Phase 3 Trial of Covid Vaccine
Five sites across India are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology Secretary Renu Swarup said on Monday. The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to...